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Abstract
The isomeric structure of high-mannose N-glycans can significantly impact biological recognition 
events. Here, the utility of travelling-wave ion mobility-mass spectrometry (TW IM-MS)for 
isomer separation of high-mannose N-glycans is investigated. Negative ion fragmentation using 
collision-induced dissociation (CID) gave more informative spectra than positive ion spectra with 
mass-different fragment ions characterizing many of the isomers. Isomer separation by ion 
mobility in both ionization modes was generally limited, with the arrival time distributions (ATD) 
often showing little sign of isomers. However, isomers could be partially resolved by plotting 
extracted fragment ATDs of the diagnostic fragment ions from the negative ion spectra and the 
fragmentation spectra of the isomers could be extracted by using ions from limited areas of the 
ATD peak. In some cases, asymmetric ATDs were observed but no isomers could be detected by 
fragmentation. In these cases, it was assumed that conformers were being separated. Collision 
cross sections (CCSs) of the isomers in positive and negative fragmentation mode were estimated 
from TW IM-MS data using dextran glycans as calibrant. More complete CCS data were achieved 
in negative ion mode by utilizing the diagnostic fragment ions. Examples of isomer separations are 
shown for N-glycans released from the well-characterized glycoproteins chicken ovalbumin, 
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porcine thyroglobulin and gp120 from the human immunodeficiency virus. In addition to the cross 
sectional data, details of the negative ion collision-induced dissociation (CID) spectra of all 
resolved isomers are discussed.
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Introduction
Glycans play a key role in the folding of cell-surface and secreted glycoproteins and their 
chemical composition and precise isomeric structure can determine glycoprotein activity and 
biological recognition events1,2. These functions are wide ranging and include recognition 
by endogenous lectins recognition in intracellular glycoprotein trafficking, cellular targeting, 
and glycoprotein turnover and even activity. Similarly, glycans also play an important role in 
self/non-self discrimination in the immune system3. Approximately half of all proteins are 
estimated to be glycosylated either at serine or threonine (termed O-linked) or at asparagine 
in an Asn-Xxx-Ser(Thr) motif where Xxx is any amino acid except proline (termed N-
linked)4. The N-linked glycans are biosynthesised by the pathway outlined in Scheme 15. In 
most species, including mammals, the glycan Glc3MangGlcNAc2 (1) is first attached to the 
protein and then reduced to Man5GlcNAc2 (17) by the action of a series of glycosidases. α-
Glucosidases first remove the three glucose residues to give Man9GlcNAc2 (4) after which 
α1→2-mannosides remove the outer mannose residues from all three antennae to give 
Man5GlcNAc2 (17). These glycans are termed “high-mannose” glycans. GlcNAc-transferase 
I then adds a GlcNAc residue to the 3-(d1) antenna of Man5GlcNAc2 (17, the three antennae 
are numbered as shown in structure 17) to produce glycan 20 which is a substrate for further 
mannosidase action to remove the two mannose residues from the 6-(d3) antenna to give 19. 
This glycan is then a substrate for further glycosyltransferases that add residues to form a 
series of complex glycans (discussed in a future paper). A second pathway involving the 
action of an endomannosidase on glycan 1 cleaves the terminal mannose with its attached 
glucose residues to give a second isomer of Man8GlcNAc2 (6) which is eventually degraded 
to 17 by α-mannosidases.
High-mannose glycans have emerged as key targets in vaccine design against the human 
immunodeficiency virus (HIV)6,7. HIV is an enveloped virus with the sole target for 
antibody neutralisation being the glycoprotein, Env, containing a trimer of gp120/gp41 
heterodimers. Approximately 50% of the mass of gp120 is formed by N-linked 
glycosylation and this high density of glycans leads to steric obstruction of the typical 
biosynthetic pathway of mannosidase cleavages and development of complex glycans8,9 
resulting in about two thirds of the glycans being stalled at the high mannose stage9. 
Importantly, broadly neutralising antibodies have been identified that bind epitopes 
dominated by these conserved high-mannose glycans10,11. Their analysis is, thus, important 
in the structural elucidation of these epitopes and in the design and quality control of vaccine 
candidates12.
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For structural analysis, N-glycans are typically released from the glycoproteins by chemical 
or enzymatic processes and analysed by techniques such as high-performance liquid 
chromatography (HPLC), often with exoglycosidase digestion or mass spectrometry 
(MS)13-17. One of the problems encountered with these analyses is that many of the glycans 
are typically released as mixtures of isomers. Mass spectrometry, normally performed in 
positive ion mode, is useful in assigning compositions and providing branching and linkage 
information from these compounds but it is not a very powerful technique for discriminating 
between isomers. Prior separation by chromatographic inlet systems is, thus, frequently used 
with consequent increases in analysis time.
Positive ion mass spectrometry methods using native, permethylated18-21 or reducing 
terminal-derivatized glycans22,23 are the techniques used by most investigators although the 
newer methods such as electron-transfer dissociation (ETD)24,25, electron-detachment 
dissociation (EDD)26,27 and electronic excitation dissociation (EED)28 are being 
increasingly employed. Spectra produced by these techniques are often rich in structural 
details but often difficult to interpret because the branched nature of N-glycans and the 
presence of many fragments formed by concomitant losses of sugar residues in glycosidic 
cleavages (between the sugar rings) from several sites. We have been investigating the use of 
negative ion fragmentation for such studies and have found that the relatively simple spectra, 
that contain mainly cross-ring fragments, are much easier to interpret and provide more 
specific structural information than positive ion spectra. Such information includes the 
ability to detect isomers because of mass shifts in diagnostic ions rather than the abundance 
differences typical of positive ion spectra29-32.
Ion mobility mass spectrometry (IM-MS) is also of potential use for isomer separation 
because it relies not only on the mass and charge but also on the size and shape of the 
glycans for separation and has recently become commercially available on research-grade 
instruments. The object of the present work is to evaluate its use, combined with negative 
ion fragmentation, for structural studies on the high-mannose glycans. Ion mobility has 
already proved to be an excellent method for examining N-glycans33-51, particularly where 
sample amounts are limited52, and has been used to extract glycan ions from complex 
mixtures, particularly in cases where samples contain only small amounts of glycan and 
large amounts of other compounds such as buffer salts39,41,53-56. Separation of peptides 
from glycopeptides has also been reported57. If isomer separation were also to be realised by 
ion mobility, its combination with negative ion fragmentation would provide one of the most 
powerful methods for glycan identification available.
Isomer separation by ion mobility has been shown for small carbohydrates (mono- to 
octasaccharides)58-79 and several N-glycans47,49 but resolution on current commercial 
instruments80 is usually only sufficient to resolve small carbohydrates. Nevertheless, 
Jackson et al.81 have been able to differentiate the larger compounds, GD1a and GD1b 
glycosphingolipids as caesium adducts; these compounds are isomeric in that they have 
sialic acid attached to different portions of the hexasaccharide moiety. Isailovic et al.45 have 
noted differences in the arrival time distribution (ATD) profiles of sialylated biantennary N-
glycans from human serum but specific structures were not identified. Plasencia et al.47 
observed three peaks in the drift time profile from the doubly charged ion from the glycan of 
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composition Hex5GlcNAc4 (per-methyl derivative) obtained from chicken ovalbumin and 
proposed three isomeric structures although, again, these structures were not confirmed by 
fragmentation. High-mannose N-glycans do not appear to have been extensively studied by 
ion mobility to date82. This paper evaluates the use of travelling-wave ion mobility mass 
spectrometry (TW IM-MS), combined with negative ion fragmentation, for determining the 
structures of high-mannose glycans released from several glycoproteins with particular 
reference to HIV gp120 glycans33,38.
Materials and Methods
Materials
N-linked glycans were released with hydrazine83,84 from the well-characterised 
glycoproteins ribonuclease B85,86 (compounds 4, 7, 11, 14, 17), porcine thyroglobulin87,88 
(compounds 4, 7, 10, 11, 14, 17), chicken ovalbumin89-91 (compounds 11, 14, 17, 19) and 
bovine fetuin92 obtained from Sigma Chemical Co. Ltd., Poole, Dorset, UK. N-glycans from 
gp120 expressed in human embryonic kidney (HEK) 293T cells (compounds 4, 7, 10, 11, 
14, 17) were released with protein N-glycosidase F (PNGase F) from within NuPAGE gels 
essentially as described by Küster et al.41,93. Briefly, the glycoprotein (20 μg) was separated 
from other glycoproteins on sodium dodecyl sulfate (SDS) polyacrylamide electrophoresis 
(PAGE) gels (NuPage 4-12% Bis-Tris SDS-PAGE gel (Invitrogen, Paisley, UK)) using 3-(N-
morpholino)propanesulfonic acid (MOPS) running buffer (Invitrogen). After staining with 
Coomassie blue dye, the band containing the glycoprotein was excised, destained, and 
PNGase F (6 mM sodium bicarbonate buffer pH 7.5) was infused into the gel. The gel pieces 
were incubated overnight (about 16 hours) at 37°C and the released glycans were extracted 
with several additions of water. For glycan purification, the solution was filtered with an 
0.45 μm hydrophobic protein binding Immobilon membrane held in a 96-well MultiScreen 
sterile plate (Millipore, Billerica, MA, USA). The glucose-containing high-mannose glycans 
(compounds 1, 22, 23) and the glycan (6) produced by the endomannosidase pathway, were 
obtained from cells treated with the α-glucosidase-inhibiting compound N-butyl-
deoxynojirimycin (NB-DNJ). The d1d2d3-isomer of Man8GlcNAc2 (6), and the d3-isomer 
of Man6GlcNAc2 (13) were obtained from gp120 from the JRCSF clade of HIV grown in 
the presence of the α-mannosidase inhibitor, kifunensine. The Man8GlcNAc2 d1d1d2 isomer 
(5) and two glycans (26, 27, Scheme 2) containing the mannose branch on the 3-antenna 
were from a Saccharomyces cerevisiae mutant and were gifts from Dr S. E. H. Moore and I. 
Chantret (Paris). Compounds 15 and 21 were from gp120 that had been treated with α-
mannosidase. Reference samples of Man5GlcNAc2 (17), Man6GlcNAc2 (d1 isomer, 14), 
Man7GlcNAc2 (d1,d1 isomer, 11), Man8GlcNAc2 (d1d1d3 isomer, 7) and Man9GlcNAc2 (4) 
were obtained from Dextra Laboratories, (Reading, UK). Methanol was obtained from BDH 
Ltd. (Poole, UK) and ammonium phosphate was from Aldrich Chemical Co. Ltd. (Poole) 
and BDH. Dextran from Leuconostoc mesenteroides was obtained from Fluka (Poole).
All glycan samples were cleaned with a Nafion 117 membrane as described earlier by 
Börnsen et al.94. Samples were then dissolved in a solution of methanol:water (1:1, v:v) 
containing ammonium phosphate (0.05 M, to maximize formation of [M+H2PO4]− ions, the 
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ions usually encountered from biological samples) and centrifuged at 10,000 rpm (9503 × g) 
for 1 min to sediment any particulates before examination by mass spectrometry.
Ion mobility mass spectrometers
TW IM-MS experiments were carried out mainly with a Waters Synapt G2 instrument 
(Waters Corp., Manchester UK)95 fitted with a nano-electrospray (n-ESI) ion source. 
Samples were infused through Waters thin-wall nanospray capillaries. The instrument was 
set up as follows: ESI capillary voltage, 1.2 kV; cone voltage, 120 V, ion source temperature, 
80°C; T-wave velocity, 450 m/sec; T-wave peak height 40 V. The T-wave mobility cell 
contained nitrogen and was operated at a pressure of 0.55 mbar. Collision-induced 
dissociation (CID) was performed after mobility separation in the transfer cell with argon as 
the collision gas. The instrument was externally mass-calibrated with sialylated N-glycans 
released from bovine fetuin. The mobility cell was calibrated with (Glc)2-13 glycans present 
in dextran (from Leuconostoc mesenteroides) as described below. Data acquisition and 
processing were carried out using the Waters Driftscope (version 2.8) software and 
MassLynx™ (version 4.1). A few spectra (see text) were also obtained with the earlier 
version of the Synapt instrument (termed the G1 version) and with a Waters Synapt G2Si 
instrument using conditions similar to those above. The scheme devised by Domon and 
Costello96 was used to name the fragment ions with the following exception: the subscript R 
(for Reducing terminal) is used when general reference is made to loss of a GlcNAc residue 
from the reducing terminus of the glycan in order to avoid confusion caused by the subscript 
number changing as the result of altered chain lengths.
CCS Estimation
Absolute helium and nitrogen CCSs of singly charged dextran oligomers (Glc3-Glc13), 
measured previously using a modified Synapt high-definition (HDMS)97 (Waters) 
quadrupole/IMS/oa-TOF MS instrument containing a linear (not travelling wave) drift tube 
(DT) IM cell were used to estimate glycan CCSs from TW IM-MS data.98-100. Sample 
introduction and instrument set-up was as above. Estimation was performed with the method 
described by Thalassinos et al.101 and compared with measurements made using the drift 
tube instrument102. Extrapolated helium cross sections were obtained from the linear 
correlation plot (r2 = 0.99899) of the nitrogen and helium cross-section data from dextran 
obtained with the DT instrument (for positive ion data see100).
Other spectra
The spectrum of glucose-containing compound 25 (Scheme 1) was obtained with a Waters 
quadrupole-time-of-flight (Q-Tof) Ultima Global instrument mass spectrometer. Samples in 
1/1 (v/v) methanol:water containing 0.5 mM ammonium phosphate were infused through 
Proxeon (Proxeon Biosystems, Odense, Denmark) nanospray capillaries. The ion source 
conditions were: temperature, 120°C; nitrogen flow 50 L/hr; infusion needle potential, 1.2 
kV; cone voltage 100 V; RF-1 voltage 150 V. CID spectra (argon, 2 sec scans) were acquired 
with a digitization rate of 4 GHz and processed as above.
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Results
Calibration standard for collision cross section measurements
Little has so far been published on calibration of TW IM-MS instruments in negative ion 
mode. Forsythe et al.103 have used polyalanine and polymalic acid but the mass range 
covered by these calibrants is insufficient for constructing a calibration for N-glycans. A 
general purpose calibration standard for calculating CCSs of N-glycans in the TW IM-MS 
instrument should ideally be a readily available glycan mixture104. Dextran oligomers from 
Leuconostoc mesenteroides would appear to fit these requirements. This mixture of glucose 
oligomers is readily obtainable and produces singly charged ions across the mass range 
covered by the N-glycans. Positive ion CCSs of the singly charged oligosaccharides were 
measured in nitrogen and helium with the DT IM-MS instrument and the nitrogen CCSs 
were calculated by the method described by Thalassinos et al.101. Peak centroids of the ATD 
peaks from the Glc2 to Glc13 oligomers from this dextran mixture were then measured with 
the TW IM-MS instrument, in nitrogen, and used to obtain a calibration in the form of y = 
Axn where y and x are the corrected dextran cross sections and drift times respectively. Full 
details have been published102. All cross sections will be added to the GlycoMob database 
(http://www.glycomob.org)105.
High-mannose glycans, Positive ions
Positive ion TWIMS nitrogen cross sections of the N-glycans released from the various 
glycoprotein samples recorded over a three year period were then measured and the results 
averaged and compared with the corresponding cross-sections measured with the linear 
instrument. Correlation was good across the range for the Man5-9GlcNAc2 glycans (4, 7, 11, 
14, 17) (Table 1). Extrapolated helium cross-sections were estimated with the aid of the 
nitrogen:helium correlation plot and are also listed in Table 1. Again, these agreed 
reasonably well with those obtained directly with the linear instrument but were, in 
agreement with previous observations102, not as good as the nitrogen data.
In order to see if any structural correlations could be made from the cross-section 
measurements, cross sectional data were plotted against hexose number for the high-
mannose glycans (Figure 1). This plot shows a generally linear relationship for the 
Man5-7GlcNAc2 glycans and the d1d1d2-isomer (5) of Man8GlcNAc2 (see structure 17, 
Scheme 1 for the labelling of the antennae), but showed a shift towards longer drift times for 
the Man8GlcNAc2 d1d1d3-isaomer (7) and Man9GlcNAc2 (4) glycans.
These glycans contained an additional mannose residue in the d3 branch of the 6-antenna. 
Although this relationship was consistently observed for the Man5-9GlcNAc2 glycans, it was 
not observed for the three glycans (1, 22, 23) containing the Glc3 substitution in the 3-
antenna.
Resolution of all isomers was not achieved in positive ion mode, but in negative mode many 
isomers could be partially resolved by examination of fragment ions.
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High-mannose glycans, Negative ions
As emphasised in earlier publications29,32, negative ion fragmentation spectra of 
underivatized N-glycans, although usually simpler than their positive ion counterparts, 
contain very diagnostic ions, mainly produced by cross-ring cleavages, and providing more 
specific structural information than positive ion spectra. Most significantly, isomers usually 
produced large mass differences in diagnostic fragment ions unlike many positive ion 
spectra where isomeric differences are reflected in the relative abundances of glycosidic 
fragment ions. This mass-different property allows ATDs of isomers to be extracted from 
fragmentation data by using profiles of isomer-specific fragments106,107. Many of the ions in 
the glycan mixtures obtained from the glycoproteins used in this work were produced by 
isomeric compounds, some of which gave clear mobility differences as reflected in bimodal 
or asymmetric ATD peaks. In some other cases, only slight broadening of the ATD peaks 
was observed. Nevertheless, the presence of isomers could still be detected by the mobility 
profiles of diagnostic negative ion fragments, as described in the examples below. Thus, 
cross sections of single compounds were calculated directly from the ATDs, whereas, when 
isomers were present, the relevant fragment ion peaks were sampled from their CID spectra 
obtained from the transfer cell. ATDs from these latter spectra exhibited an approximately 
220 μsec shift to shorter drift times than the corresponding unfragmented ATDs, requiring 
the relevant correction to be made. Using these methods, negative ion cross-sections were 
obtained for most of the isomeric high-mannose glycans in Scheme 1 and related 
compounds and are listed in Table 2. Validation of the method for measuring isomer cross 
sections from fragment ions was made by comparing the nitrogen values obtained using a 
linear drift cell with those of the isolated isomers (Dextra Laboratories) where close 
agreement was found (Table 2, Column 8). The values are also compared with those 
measured from the biological samples with the linear drift cell instrument; these latter values 
are the averages for glycans released from ovalbumin, ribonuclease B and porcine 
thyroglobulin100 because the lower resolution of this instrument did not permit isomer 
separation. They are listed against the most abundant isomer as determined with the Synapt 
G2 instrument in Table 2 (Column 10). Agreement between the linear and TW IM-MS 
instruments was reasonable but not as good as with the reference isomers.
General features of the negative ion fragmentation spectra
Details of the negative ion fragmentation spectra for several of the compounds have been 
reported in earlier publications29,32,108, others are reported here. Briefly: 2,4AR, BR-1 
and 2,4AR-1 ions (2,4A5, B5 and 2,4 A5 at m/z 1072, 1012 and 869 respectively in, for 
example, the spectrum of Man5GlcNAc2 (17) shown in Figure 2a) define the 1→4-linked 
chitobiose core, the D, D-18, 0,3AR-2, 0,4aR-2 and B2α ions (m/z 647, 629, 575, 545 and 503 
respectively in Figure 2a) and the D’ ion at m/z 323 define the branching pattern and the C1 
ion at m/z 179 characterizes the hexose (mannose or glucose) residues on the non-reducing 
termini of the antennae. The D, D-18, 0,3AR-2, 0,4AR-2 and Bα ions will be referred to later in 
this paper as the “6-antenna-specific ions” and uniquely define all of the isomers expected in 
biological samples as shown in Table 3. It is important when recording the spectra of these 
compounds that the collision energy is not too high. As the collision energy rises, the 
fragmentation changes from that shown in Figure 2a to one in which the spectrum lacks the 
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diagnostic fragments and is dominated by a series of (mannose)n-CH=CH-O− cross-ring 
fragments (Figure 3d) in a similar way to ions from endoH-released glycans reported 
earlier109. For Man5GlcNAc2 (17), for example, shown in Figure 3, the diagnostic fragments 
are present in spectra recorded at about 75 V (Figure 3c) on the collision cell but are 
replaced by the other ions above 105 V. The plots in Figure 3a and b show the energy-
resolved profiles for some of the main diagnostic ions (Figure 3a) and for the (mannose)n-
CH=CH-O− cross-ring fragments (Figure 3b).
Man3-5GlcNAc2 (15, 17, 18, 19, 21)—The spectrum of Man5GlcNAc2 (17) is reported 
above. The D and D-18 ions at m/z 323 and 305 in the spectrum of Man3GlcNAc2 (19, 
Figure 2e) were 324 mass units below the masses of the corresponding ions in the spectrum 
of Man5GlcNAc2 (17) reflected the absence of mannose residues attached to the 6-antenna. 
The spectrum shown in Figure 2c is of a mixture of the Man4GlcNAc2 isomers 15 and (18, 
21) as shown by the two sets of D, D-18, 0,3A3, 0,4A3 ions at m/z 323, 305, 251, 221 and at 
m/z 485, 467, 413 and 383 respectively. The mixture gave a slightly asymmetric ATD peak 
(Figure 4a) consistent with the presence of isomers. ATDs of the D, D-18, 0,3A3, 0,4A3 ions 
(Figure 4b) showed that the ions in each set maximized at the same drift time but that there 
was a distinct difference between the drift times of each set showing partial separation of the 
isomers. The isomer with the longest drift time contained the fourth mannose in the 6-
antenna (compounds 18 and 21) and represented a similar situation to the separation of 
isomers of Man3GlcNAc3, reported earlier49. These latter two compounds had the 
trimannosyl-chitobiose core with an additional GlcNAc residue substituted on either antenna 
with the compound containing the GlcNAc residue in the 6-antenna showing the longest 
drift time.
By using only ions from the first part of the ATD peak of the Man4GlcNAc2 isomers, shown 
in Figure 4a, it was possible to extract a relatively clean spectrum of the 3-substituted isomer 
15 (Figure 2b). The spectrum shown in Figure 2d is that of the isomer(s) (18 and 21) with 
the fourth mannose in the 6-antenna. Not only did this method allow properties of the 
individual isomers to be extracted but it also confirmed that the presence of the two sets of 
diagnostic fragment ions seen in the total MS/MS spectra, as would be obtained without 
mobility separation, were indeed from isomeric compounds.
CCSs of Man3GlcNAc2 (19) and Man5GlcNAc2 (17), calculated directly from the ATD 
peaks are listed in Table 2. CCSs of the Man4GlcNAc2 isomers (15, (18, 21)) were obtained 
from the ATD profiles of the diagnostic fragment ions with correction for the drift time 
offset mentioned above.
Man6GlcNAc2 (12-14)—Three biologically-relevant isomers (12-14) of this glycan are 
possible with the 6th mannose terminating one of the three antennae of 17. The d1 isomer 
(14, Figure 5c) is the most commonly found isomer in glycoproteins such as ribonuclease B 
and thyroglobulin and the fragment ions defining the branching pattern arising from the 6-
antenna, are observed at the same m/z values as in the spectrum of Man5GlcNAc2 consistent 
with the presence of the 6th mannose in the 3-antenna. The d2-isomer (12) was obtained 
from gp120, JRCSF expressed in the presence of kifunensine. Its MS/MS spectrum (Figure 
5b) showed a shift in the D, D-18, 0,3A3, 0,4A3 and B2α ions by 162 mass units to m/z 809, 
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791, 737, 707 and 665 respectively reflecting the additional mannose residue in the 6-
antenna. Its ATD profile was very similar to that of the d1 isomer (14).
The d3 isomer (13) was obtained as a minor constituent of the glycans from gp120 that had 
also been expressed in the presence of the α-mannosidase inhibitor kifunensine. The ATD 
peak at m/z 1493 (phosphate adduct) was asymmetric (Figure 5a) and, consequently, the 
compound was fragmented in the transfer cell in order to extract the ATD of the isomeric 
constituents. Two sets of 6-antenna-specific fragment ions were present in the CID 
spectrum; those at m/z 647, 629, 575, 545 and 503 from the major compound showed that it 
was the d1 isomer (14). The other set of ions at m/z 809, 791, 737, 707 and 665 maximized 
later (Figure 5b) and confirmed the presence of the second isomer with a mannose residue 
attached to the 6-antenna. Its spectrum was obtained by selecting only the right-hand portion 
of the total ATD peak and is shown in Figure 5c. Fragment ions in this spectrum were almost 
identical to those from the d2 isomer (12) but with the addition of the D’ and D’-18 ions at 
m/z 485 and 467. These latter ions were found to be diagnostic for mannose substitution in 
the d3 position and presumably arise in a similar manner to the D and D-18 ions because of 
the common 3,6-substitution pattern of the 6-antenna. The cross-section of this compound 
was obtained by correcting the drift time from the fragmentation spectrum by a factor 
equivalent to the difference between the drift time for the d1 isomer obtained from the mass 
spectrum and from the CID spectrum as described above. It was larger than that for the other 
two isomers, consistent with the observations made for d3-substituted high-mannose glycans 
in positive ion mode.
Man7GlcNAc2 (8-11)—Four isomers of this compound are possible: the d1d1 (11), d1d2 
(8), d1d3 (10) and d2d3 (9) glycans. Spectra of the d1d1, d1d2, d1d3 isomers are shown in 
Figure 6. The d2d3 isomer (9) was not available. The spectrum of the d1d1-isomer (11, 
Figure 6a) contained 6-antenna-specific ions at the same masses as in the spectrum of 
Man5GlcNAc2 confirming no extra mannose residues in the 6-antenna. The spectra of the 
other two compounds (8, 10) showed a shift of these ions by 162 mass units consistent with 
the addition of one mannose to the 6-antenna. D’ and D’-18’ ions at m/z 485 and 467 
respectively in the spectrum of 10 (Figure 6c) and their absence in spectrum 6b confirmed 
that spectrum 6c was that of the d1d3 isomer (10). Cross-section measurements of these 
isomers (Table 2) showed that the d1d3 isomer had a considerably larger cross section than 
the other two, consistent with the similar observation from the Man6GlcNAc2 isomers 
above. Samples from various preparations of gp120 contained the d1d1 and d1d3 isomers in 
different proportions. Single ion mobilograms of the diagnostic D, D-18 etc. ions from one 
of these samples (inset to Figure 6a) showed separation of these isomers from a single 
spectrum.
Man8GlcNAc2 (5-7)—Spectra of the three possible isomers, d1d1d2 (5), d1d1d3 (7) and 
d1d2d3 (6) are shown in Figure 7. The 6-antenna-specific ions are present at m/z 809, 791, 
737, 707 and 665 respectively in the spectra of the d1d1d2- (5) and d1d1d3- (7) isomers 
reflecting the presence of the single extra mannose residue in the 6-antenna. The two 
isomers can be differentiated by the presence of the ions at m/z 485 and 467 in the spectrum 
of the d1d1d3-isomer (7) and by their cross sections; the isomer (5), missing the mannose on 
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the 6-branch showed a significantly shorter drift time and smaller cross-section. The d1d2d3 
isomer (6) displayed 6-antenna-specific ions at m/z 971, 953, 877, 869 and 827 confirming 
two additional mannose residues in the 6-antenna. Its CCS was also considerably higher than 
that of the d1d1d2-isomer (5), as expected from the presence of the mannose residue at the 
d3 position.
The d1d1d3-isomer of Man8GlcNAc2 (7) is normally the major isomer in biological systems 
but, in most samples studied, its ATD peak was asymmetric (Inset, Figure 7a) with a slight 
shoulder on the leading edge suggesting the presence of a second isomer. Spectra extracted 
from the leading and trailing edges of the ATD peak following transfer cell fragmentation 
were virtually identical. The presence of the D’ and D-18’ ions at m/z 485 and 467 with the 
same mobility profile as that of the total ion profile showed that a minor isomer, if present, 
was also substituted at the d3 position and would, thus correspond to compound 6. Cross-
section measurements of this compound, the d1d2d3-isomer, obtained as the product of 
endomannosidase digestion was less than that of the major d1d1d3-isomer (7) (although 
larger than that of the d1d1d2-isomer, 5) and was consistent with the shoulder on the major 
peak. Close inspection of the fragmentation spectrum showed very low abundance ions 
corresponding to the D, D-18, 0,3A3, 0,4A3 and B2α ions expected from this isomer but 
which would not normally be of sufficient relative abundance to give confidence that they 
signified the presence of a second isomer. However, their different drift times from those of 
the major peaks confirmed their origin from compound 6. The presence of this isomer is 
consistent with the enzymology of the expression system use to produce the glycoprotein 
and shows that it is most probably formed as a product of an endomannosidase (Scheme 1).
Man9GlcNAc2 (4)—Man9GlcNAc2 from ribonuclease B, thyroglobulin and gp120 is a 
single isomer (4) as would be expected on biochemical grounds and confirmed by its CID 
spectrum (Figure 8c). The 6-antenna-specific ions at m/z 871, 953, 877, 869 and 827 are 
consistent with the composition of the 6-antenna with the ions at m/z 485 and 467 reflected 
the presence of mannose in the d3 branch. The Synapt G1 instrument gave a roughly 
Gaussian peak for this glycan but the G2 instruments produced an asymmetric ATD peak 
from the glycan from all three glycoproteins (Figure 9a). ATD profiles of the diagnostic 
fragment ions all matched that of the molecular ion suggesting that conformers were being 
separated (Figure 9b). Reduction of the glycans (to be published) removed the asymmetry 
indicating that anomer separation was the main reason for the un-symmetrical ATDs. 
Anomer separation of small carbohydrates (mainly as [M+Na]+ ions from methyl 
glycosides) by ion mobility has been noted by several investigators34,58,59,68,110 and 
pronounced effects on the conformation of the GlcNAc-β1→4GlcNAc disaccharide 
(equivalent to the chitobiose core of the N-linked glycans) have been noted by X-ray 
crystallography111,112 as reported by Wood et al113. However, the effect was not seen with 
the smaller high-mannose glycans suggesting that the anomer configuration can affect more 
than just the chitobiose core. For positive ion spectra ([M+Na]+ ions), Dwivedi et al.60 have 
proposed that separation reflects the way in which the sodium ion is bound to the glycan and 
a similar situation may exist for negative ion spectra. The CCS data from the G2 instrument 
are from smoothed ATD peaks. In some of the gp120 samples, a trace amount of a 
compound consistent with Glc1Man8GlcNAc2 (24) was detected as producing diagnostic 
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ions at m/z 545 and 383 (see below) with ATDs matching that of the second peak. This 
compound has also been detected by HPLC in these gp120 samples but its abundance was 
not sufficient to account for the asymmetric ATD peak and it was not detected in the other 
samples.
Glycans from Saccharomyces cerevisiae—Two glycans, Man9GlcNAc2 (26) and 
Man10GlcNAc2 (27, Scheme 2) were obtained from Saccharomyces cerevisiae mutants with 
structures that differed from the above in that they contained an extra mannose at the 6-
position of the internal mannose of the 3-antenna114. Their spectra are shown in Figure 8b 
and 8d respectively, together with those of Man8GlcNAc2 (d1d1d3 isomer 7, Figure 8a) and 
Man9GlcNAc2 (4, Figure 8c) for comparison, and their cross-sections are listed in Table 2. 
The d1d1d3- and d1d1d2d3-substitution of these glycans was confirmed by the D, D-18 
series of ions and the absence of glucose residues on the 3-antenna (Hex10GlcNAc2 could be 
Glc1Man9GlcNAc2 (3) rather than Man10GlcNAc2, (27)) was reflected by the absence of the 
prominent cross-ring fragments at m/z 545 and 383 (one glucose residue, see section below). 
The spectra were virtually identical to those of the corresponding glycans without the 6-
substituted mannose in the 3- antenna meaning that no suitable diagnostic ion for this 
substitution was present. The ATD profiles from these two Saccharomyces cerevisiae 
glycans were symmetrical (Figure 9c) as were those of the 6-antenna-specific fragment ions 
(Figure 9d).
Glc3Man7-9GlcNAc2 (1, 22, 23)—These glycans were produced by expressing gp120 in 
CHO cells in the presence of the α-glucosidase inhibitor N-butyl-deoxynojirimycin (NB-
DNJ) which prevents removal of the glucose residues from Glc3Man9GlcNAc2 (1) at the 
start of N-glycan processing115 and, thus, prevents degradation of the 3-antenna by exo-
mannosidases. Under these conditions, the action of α-mannosidase I only removes one and 
two mannose residues from the 6-antenna to give 22 and 23. 1,3A cross-ring fragmentation 
of the intact Glc3Man3 antenna of these compounds gave rise to the prominent ions at m/z 
869 and 707 (Figure 10c-d). D and D-18 ions appeared to be suppressed in the spectra of 
these compounds although the B3β ion at m/z 809 was prominent in the spectrum of 
Glc3Man9GlcNAc2 (1). The prominent ions at m/z 869 and 707 were diagnostic of these 
glycans with three glucose residues in the 3-antenna and dropped to 707:545 and to 545:383 
for related glycans with two and one glucose residues respectively (Figure 10a). 
Unfortunately, the CID spectrum of compound 25 was recorded with a Q-TOF mass 
spectrometer, before the advent of the Synapt series of instruments and, consequently, its 
drift time was not available.
The cross sections of the Glc3Man7 and 9GlcNAc2 glycans (23, 1) are listed in Table 2. 
Although the ATD profiles of Glc3Man7GlcNAc2 (23) and Glc3Man9GlcNAc2 (1) were 
roughly symmetrical, that from Glc3Man8GlcNAc2 (22) was very broad (first inset, Figure 
10a). The fragmentation spectra extracted from all areas of the ATD peak were similar and 
the intact 3-antenna (confirmed by the presence of the ions at m/z 869 and 707) was 
consistent with the absence of one of the mannose residues from the 6-antenna. However, 
some of the ATDs of the fragment ions, particularly m/z 971 (Hex6, B6α) showed separation 
into two peaks but it was unclear if these represented the d1d1d2- and d1d1d3-isomers; the 
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ion diagnostic for the d3 isomer maximized in the centre of the ATD peak. Possibly 
conformers were present and this point is being pursued further.
A plot of all the measured CCSs against hexose number for all of the high-mannose glycans 
recorded in negative ion mode is shown in Figure 11. In general, the same features were 
apparent as seen in the corresponding positive ion plot (Figure 1). Thus, the Man8GlcNAc2 
(7) and Man9GlcNAc2 (4) glycans with mannose at the d3 position again showed increased 
cross sections compared with those of their respective isomers. This observation was 
supported by the additional CCSs of the d3 isomer of Man6GlcNAc2 (13), and the d1d3 
isomer of Man7GlcNAc2 (10), both of which showed larger cross sections than the isomers 
without the d3-mannose. No significant differences were seen in the cross sections of the 
glycans with extra mannose residues in the d1 and d2 positions. Again the results from the 
Glc3-containing glycans did not fit this pattern but may have been obscured by the presence 
of conformers causing considerable peak broadening.
Discussion
The above examples clearly show that ion mobility mass spectrometry adds a further 
dimension to the analysis of N-linked carbohydrates by mass spectrometry. Some isomeric 
separation was possible in both ion modes but could be detected more fully in negative ion 
mode where the presence of isomers was reflected by differences in the masses of certain 
diagnostic fragments. Characteristic drift-time increases were seen with glycans containing 
mannose substitution on the d3-branch of the 6-antenna. IM resolution is still rather poor on 
commercial instruments and for several of the high-mannose glycans, only peak broadening 
or asymmetric peaks suggested the presence of isomers. Unfortunately, similar results were 
seen in the presence of conformers, which were also partially separated by ion mobility mass 
spectrometry. However, because negative ion fragmentation frequently yields ions from 
isomers that differ in mass, individual ATDs of these ions show different maxima and, when 
superimposed on the total ATD profile, enabled isomers and conformers to be differentiated. 
The corresponding experiment performed upon conformers, not isomers, gave ATD traces 
from the fragment ions that matched the shape of the total ATD peak.
The ability of ion mobility to separate isomers, albeit with rather low resolution at present, is 
a great asset. One of the main disadvantages of the use of mass spectrometry (without 
fragmentation) for glycan analysis at present is its inability to separate such compounds and, 
thus, identifying their presence in mixed spectra. The ion mobility resolution obtained with 
commercial instruments does not yet match that of an HPLC column but is expected to rise 
with further instrumental developments. Ultimately, it might be possible to achieve adequate 
separations in the gas phase in milliseconds rather than the tens or hundreds of minutes 
required at present with LC-MS systems, thus considerably expediting up analyses.
Conclusions
The work presented here, and by other investigators, shows that ion mobility mass 
spectrometry has much to offer in glycobiology and is able to solve problems such as isomer 
resolution that, up to now, have required techniques such as chromatography. With its ability 
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to extract glycan ions from complex mixtures and, thus, eliminate some clean-up stages41, 
and with its combination with negative ion CID spectra, the technique provides a much more 
rapid and information-rich method for the structural determination of N-glycans than has 
been available up to now.
Acknowledgements
We thank Professor Raymond Dwek for his help and encouragement and Drs Stuart Moore and Isabelle Chantret 
(INSERM, Paris) for the gift of the d1d2 isomer of Man8GlcNAc2 and of the two glycans containing the extra 
mannose residue in the 3-antenna. This work was supported by the International AIDS Vaccine Initiative 
Neutralizing Antibody Center CAVD grant (Glycan characterization and Outer Domain glycoform design) and the 
Scripps CHAVI-ID (1UM1AI100663).
Abbreviations
ATD arrival time distribution
CHO Chinese hamster ovary
CID collision-induced dissociation
DT drift tube
EDD electron-detatchment dissociation
EED electronic excitation dissociation
endoH endoglycosidase H
ETD electron-transfer dissociation
ESI electrospray ionization
G1 Waters Synapt ion mobility mass spectrometer, first generation
G2 Waters Synapt ion mobility mass spectrometer, second generation
Glc glucose
GlcNAc N-acetylglucosamine
HDMS high-definition
HEK human embryonic kidney
HIV human immunodeficiency virus
HPLC high-performance liquid chromatography
Hex hexose
LC liquid chromatography
JRCSF clade of gp120
Man mannose
MS mass spectrometry
n-ESI nano-electrospray ionization
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NB-DNJ N-butyl-deoxynojirimycin
NMR nuclear magnetic resonance
oa orthogonal acceleration
PAGE polyacrylamide gel electrophoresis
PNGase F protein N-glycosidase F
Q quadrupole
SDS sodium dodecylsulfate
TOF time-of-flight
TW IM-MS travelling-wave ion mobility spectrometry
References
[1]. Petrescu AJ, Wormald MR, Dwek RA. Structural aspects of glycomes with a focus on N-
glycosylation and glycoprotein folding. Curr. Opin. Struct. Biol. 2006; 16:600–607. [PubMed: 
16938454] 
[2]. Dalziel M, Crispin M, Scanlan CN, Zitzmann N, Dwek RA. Emerging principles for the 
therapeutic exploitation of glycosylation. Science. 2014; 343:1235681. [PubMed: 24385630] 
[3]. Gagneux P, Varki A. Evolutionary considerations in relating oligosaccharide diversity to biological 
function. Glycobiology. 1999; 9:747–755. [PubMed: 10406840] 
[4]. Varki, A.; Cummings, RD.; Esko, JD.; Freeze, HH.; Stanley, P.; Bertozzi, CR.; Hart, GW.; Etzler, 
ME. Essentials of Glycobiology. Second. Cold Spring Harbor Laboratory Press; 2008. 
[5]. Lannoo N, Van Damme EJM. Review/N-glycans: The making of a varied toolbox. Plant Sci. 2015; 
239:67–83. [PubMed: 26398792] 
[6]. Scanlan CN, Offer J, Zitzmann N, Dwek RA. Exploiting the defensive sugars of HIV-1 for drug 
and vaccine design. Nature. 2007; 446:1038–1045. [PubMed: 17460665] 
[7]. Crispin M, Doores KJ. Targeting host-derived glycans on enveloped viruses for antibody-based 
vaccine design. Curr Opin. Virol. 2015; 11:63–69. [PubMed: 25747313] 
[8]. Pritchard LK, Spencer DIR, Royle L, Bonomelli C, Seabright GE, Behrens A-J, Kulp DW, Menis 
S, Krumm SA, Dunlop DC, Crispin DJ, Bowden TA, Scanlan CN, Ward AB, Schief WR, Doores 
KJ, Crispin M. Glycan clustering stabilizes the mannose patch of HIV-1 and preserves 
vulnerability to broadly neutralizing antibodies. Nat. Commun. 2015; 6 Article 7479. 
[9]. Pritchard LK, Harvey DJ, Bonomelli C, Crispin M, Doores K. J. Cell- and protein-directed 
glycosylation of native cleaved HIV-1 envelope. J. Virol. 2015; 89:8932–8944. [PubMed: 
26085151] 
[10]. Pejchal R, Doores KJ, Walker LM, Khayat R, Huang PS, Wang SK, Stanfield RL, Julien JP, 
Ramos A, Crispin M, Depetris R, Katpally U, Marozsan A, Cupo A, Maloveste S, Liu Y, 
McBride R, Ito Y, Sanders RW, Ogohara C, Paulson JC, Feizi T, Scanlan CN, Wong CH, Moore 
JP, Olson WC, Ward AB, Poignard P, Schief WR, Burton DR, Wilson IA. A potent and broad 
neutralizing antibody recognizes and penetrates the HIV glycan shield. Science. 2011; 334:1097–
1103. [PubMed: 21998254] 
[11]. Burton DR, Ahmed R, Barouch DH, Butera ST, Crotty S, Godzik A, Kaufmann DE, McElrath 
MJ, Nussenzweig MC, Pulendran B, Scanlan CN, Schief WR, Silvestri G, Streeck H, Walker 
BD, Walker LM, Ward AB, Wilson IA, Wyatt R. A blueprint for HIV vaccine discovery. Cell 
Host Microbe. 2012; 12:396–407. [PubMed: 23084910] 
[12]. Pritchard LK, Vasiljevic S, Ozorowski G, Seabright GE, Cupo A, Ringe R, Kim HJ, Sanders RW, 
Doores KJ, Burton DR, Wilson IA, Ward AB, Moore JP, Crispin M. Structural constraints 
Harvey et al. Page 14
J Mass Spectrom. Author manuscript; available in PMC 2017 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
determine the glycosylation of HIV-1 envelope trimers. Cell Rep. 2015; 11:1604–1613. 
[PubMed: 26051934] 
[13]. Alley WR Jr. Mann BF, Novotny MV. High-sensitivity analytical approaches for the structural 
characterization of glycoproteins. Chem. Rev. 2013; 113:2668–2732. [PubMed: 23531120] 
[14]. Alley WR Jr. Novotny MV. Structural glycomic analyses at high sensitivity: A decade of 
progress. Annu. Rev. Anal. Chem. 2013; 6:237–265.
[15]. Harvey DJ. Proteomic analysis of glycosylation: structural determination of N- and O-linked 
glycans by mass spectrometry. Expert Rev. Proteomics. 2005; 2:87–101. [PubMed: 15966855] 
[16]. Harvey, DJ. Electrospray and MALDI Mass Spectrometry: Fundamentals, Instrumentation, 
Practicalities, and Biological Applications. 2nd. Cole, RB., editor. John Wiley and Sons Inc.; 
Hoboken, NJ, USA: 2010. p. 723-769.
[17]. Zaia J. Mass spectrometry of oligosaccharides. Mass Spectrom. Rev. 2004; 23:161–227. 
[PubMed: 14966796] 
[18]. Ciucanu I, Kerek F. A simple and rapid method for the permethylation of carbohydrates. 
Carbohydr. Res. 1984; 131:209–217.
[19]. Hakomori S. A rapid permethylation of glycolipid, and polysaccharide catalysed by 
methylsulfinyl carbanion in dimethyl sulfoxide. J. Biochem. (Tokyo). 1964; 55:205–208. 
[PubMed: 14135466] 
[20]. Dell A. Preparation and desorption mass spectrometry of permethyl and peracetyl derivatives of 
oligosaccharides. Methods Enzymol. 1990; 193:647–660. [PubMed: 2074840] 
[21]. Kang P, Mechref Y, Klouckova I, Novotny MV. Solid-phase permethylation of glycans for mass 
spectrometric analysis. Rapid Commun. Mass Spectrom. 2005; 19:3421–3428. [PubMed: 
16252310] 
[22]. Harvey DJ. Derivatization of carbohydrates for analysis by chromatography, electrophoresis and 
mass spectrometry. J. Chromatogr., B. 2011; 879:1196–1225.
[23]. Ruiz-Matute AI, Hernández-Hernández O, Rodríguez-Sánchez S, Sanz ML, Martínez-Castro I. 
Derivatization of carbohydrates for GC and GC-MS analyses. J. Chromatogr., B. 2011; 
879:1226–1240.
[24]. Han L, Costello CE. Electron transfer dissociation of milk oligosaccharides. J. Am. Soc. Mass 
Spectrom. 2011; 22:997–1013. [PubMed: 21953041] 
[25]. Zhu Z, Su X, Clark DF, Go EP, Desaire H. Characterizing O-linked glycopeptides by electron 
transfer dissociation: Fragmentation rules and applications in data analysis. Anal. Chem. 2013; 
85:8403–8411. [PubMed: 23909558] 
[26]. Zhou W, Håkansson K. Electron detachment dissociation of fluorescently labeled sialylated 
oligosaccharides. Electrophoresis. 2011; 32:3526–3535. [PubMed: 22120881] 
[27]. Kornacki JR, Adamson JT, Håkansson K. Electron detachment dissociation of underivatized 
chloride-adducted oligosaccharides. J. Am. Soc. Mass Spectrom. 2012; 23:2031–2042. [PubMed: 
22911097] 
[28]. Yu X, Jiang Y, Chen Y, Huang Y, Costello CE, Lin C. Detailed glycan structural characterization 
by electronic excitation dissociation. Anal. Chem. 2013; 85:10017–10021. [PubMed: 24080071] 
[29]. Harvey DJ. Fragmentation of negative ions from carbohydrates: Part 2, Fragmentation of high-
mannose N-linked glycans. J. Am. Soc. Mass Spectrom. 2005; 16:631–646. [PubMed: 
15862765] 
[30]. Harvey DJ. Fragmentation of negative ions from carbohydrates: Part 1; Use of nitrate and other 
anionic adducts for the production of negative ion electrospray spectra from N-linked 
carbohydrates. J. Am. Soc. Mass Spectrom. 2005; 16:622–630. [PubMed: 15862764] 
[31]. Harvey DJ. Fragmentation of negative ions from carbohydrates: Part 3, Fragmentation of hybrid 
and complex N-linked glycans. J. Am. Soc. Mass Spectrom. 2005; 16:647–659. [PubMed: 
15862766] 
[32]. Harvey DJ, Royle L, Radcliffe CM, Rudd PM, Dwek RA. Structural and quantitative analysis of 
N-linked glycans by MALDI and negative ion nanospray mass spectrometry. Anal. Biochem. 
2008; 376:44–60. [PubMed: 18294950] 
Harvey et al. Page 15
J Mass Spectrom. Author manuscript; available in PMC 2017 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
[33]. Bonomelli C, Doores KJ, Dunlop DC, Thaney V, Dwek RA, Burton DR, Crispin M, Scanlan CN. 
The glycan shield of HIV is predominantly oligomannose independently of production system or 
viral clade. PLoS One. 2011; 6:e23521. [PubMed: 21858152] 
[34]. Both P, Green AP, Gray CJ, Šardzík R, Voglmeir J, Fontana C, Austeri M, Rejzek M, Richardson 
D, Field RA, Widmalm G, Flitsch SL, Eyers CE. Discrimination of epimeric glycans and 
glycopeptides using IM-MS and its potential for carbohydrate sequencing. Nat. Chem. 2014; 
6:65–74. [PubMed: 24345949] 
[35]. Crispin M, Harvey DJ, Bitto D, Bonomelli C, Edgeworth M, Scrivens JH, Huiskonen JT, Bowden 
TA. Structural plasticity of the Semliki Forest virus glycome upon interspecies transmission. J. 
Proteome Res. 2014; 13:1702–1712. [PubMed: 24467287] 
[36]. Crispin M, Harvey DJ, Bitto D, Halldorsson S, Bonomelli C, Edgeworth M, Scrivens JH, 
Huiskonen JT, Bowden TA. Uukuniemi phlebovirus assembly and secretion leave a functional 
imprint on the virion glycome. J. Virol. 2014; 88:10244–10251. [PubMed: 24942574] 
[37]. Damen CWN, Chen W, Chakraborty AB, van Oosterhout M, Mazzeo JR, Gebler JC, Schellens 
JHM, Rosing H, Beijnen JH. Electrospray ionization quadrupole ion-mobility time-of-flight mass 
spectrometry as a tool to distinguish the lot-to-lot heterogeneity in N-glycosylation profile of the 
therapeutic monoclonal antibody Trastuzumab. J. Am. Soc. Mass Spectrom. 2009; 20:2021–
2033. [PubMed: 19744865] 
[38]. Doores KJ, Bonomelli C, Harvey DJ, Vasiljevic S, Dwek RA, Burton DR, Crispin M, Scanlan 
CN. Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens. 
Proc. Natl. Acad. Sci., USA. 2010; 107:13800–13805. [PubMed: 20643940] 
[39]. Fenn LS, McLean JA. Simultaneous glycoproteomics on the basis of structure using ion mobility-
mass spectrometry. Mol. Biosyst. 2009; 5:1298–1302. [PubMed: 19823744] 
[40]. Gaye MM, Valentine SJ, Hu Y, Mirjankar N, Hammoud ZT, Mechref Y, Lavine BK, Clemmer 
DE. Ion mobility-mass spectrometry analysis of serum N-linked glycans from esophageal 
adenocarcinoma phenotypes. J. Proteome Res. 2012; 11:6102–6110. [PubMed: 23126309] 
[41]. Harvey DJ, Sobott F, Crispin M, Wrobel A, Bonomelli C, Vasiljevic S, Scanlan CN, Scarff C, 
Thalassinos K, Scrivens JH. Ion mobility mass spectrometry for extracting spectra of N-glycans 
directly from incubation mixtures following glycan release: Application to glycans from 
engineered glycoforms of intact, folded HIV gp120. J. Am. Soc. Mass Spectrom. 2011; 22:568–
581. [PubMed: 21472575] 
[42]. Harvey DJ, Scarff CA, Crispin M, Scanlan CN, Bonomelli C, Scrivens JH. MALDI-MS/MS with 
traveling wave ion mobility for the structural analysis of N-linked glycans. J. Am. Soc. Mass 
Spectrom. 2012; 23:1955–1966. [PubMed: 22993039] 
[43]. Harvey, DJ. Encyclopedia of Biophysics. Roberts, GCK., editor. Berlin, Heidelberg; Springer: 
2013. p. 1405-1416.
[44]. Harvey DJ, Scarff CA, Edgeworth M, Crispin M, Scanlan CN, Sobott F, Allman S, Baruah K, 
Pritchard L, Scrivens JH. Travelling wave ion mobility and negative ion fragmentation for the 
structural determination of N-linked glycans. Electrophoresis. 2013; 34:2368–2378. [PubMed: 
23712623] 
[45]. Isailovic D, Kurulugama RT, Plasencia MD, Stokes ST, Kyselova Z, Goldman R, Mechref Y, 
Novotny MV, Clemmer DE. Profiling of human serum glycans associated with liver cancer and 
cirrhosis by IMS-MS. J. Proteome Res. 2008; 7:1109–1117. [PubMed: 18237112] 
[46]. Lareau NM, May JC, McLean JA. Non-derivatized glycan analysis by reverse phase liquid 
chromatography and ion mobility-mass spectrometry. Analyst. 2015; 140:3335–3338. [PubMed: 
25737268] 
[47]. Plasencia MD, Isailovic D, Merenbloom SI, Mechref Y, Clemmer DE. Resolving and assigning 
N-linked glycan structural isomers from ovalbumin by IMS-MS. J. Am. Soc. Mass Spectrom. 
2008; 19:1706–1715. [PubMed: 18760624] 
[48]. Vakhrushev SY, Langridge J, Campuzano I, Hughes C, Peter-Katalinić J. Identification of 
monosialylated N-glycoforms in the CDG urinome by ion mobility tandem mass spectrometry: 
The potential for clinical applications. Clin. Proteomics. 2008; 4:47–57.
[49]. Williams JP, Grabenauer M, Carpenter CJ, Holland RJ, Wormald MR, Giles K, Harvey DJ, 
Bateman RH, Scrivens JH, Bowers MT. Characterization of simple isomeric oligosaccharides and 
Harvey et al. Page 16
J Mass Spectrom. Author manuscript; available in PMC 2017 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
the rapid separation of glycan mixtures by ion mobility mass spectrometry. Int. J. Mass 
Spectrom. 2010; 298:119–127.
[50]. Yamaguchi Y, Nishima W, Re S, Sugita Y. Confident identification of isomeric N-glycan 
structures by combined ion mobility mass spectrometry and hydrophilic interaction liquid 
chromatography. Rapid Commun. Mass Spectrom. 2012; 26:2877–2884. [PubMed: 23136018] 
[51]. Zhu F, Lee S, Valentine SJ, Reilly JP, Clemmer DE. Mannose7 glycan isomer characterization by 
IMS-MS/MS analysis. J. Am. Soc. Mass Spectrom. 2012; 23:2158–2166. [PubMed: 23055077] 
[52]. Ackerman ME, Crispin M, Yu X, Baruah K, Boesch AW, Harvey DJ, Dugast A-S, Heizen EL, 
Ercan A, Choi I, Streeck H, Nigrovic PA, Bailey-Kellogg C, Scanlan C, Alter G. Natural 
variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity. J. Clin. Invest. 
2013; 123:2183–2192. [PubMed: 23563315] 
[53]. Fenn LS, McLean JA. Biomolecular structural separations by ion mobility–mass spectrometry. 
Anal. Bioanal. Chem. 2008; 391:905–909. [PubMed: 18320175] 
[54]. Fenn LS, McLean JA. Enhanced carbohydrate structural selectivity in ion mobility-mass 
spectrometry analyses by boronic acid derivatization. Chem. Commun. 2008:5505–5507.
[55]. Fenn LS, Kliman M, Mahsut A, Zhao SR, McLean JA. Characterizing ion mobility-mass 
spectrometry conformation space for the analysis of complex biological samples. Anal. Bioanal. 
Chem. 2009; 394:235–244. [PubMed: 19247641] 
[56]. Harvey DJ, Crispin M, Bonomelli C, Scrivens JH. Ion mobility mass spectrometry for ion 
recovery and clean-up of MS and MS/MS spectra obtained from low abundance viral samples. J. 
Am. Soc. Mass Spectrom. 2015; 26 In Press. 
[57]. Li H, Bendiak B, Siems WF, Gang DR, Hill HH Jr. Ion mobility-mass correlation trend line 
separation of glycoprotein digests without deglycosylation. Int. J. Ion Mobil. Spectrom. 2013; 
16:105–115. [PubMed: 23914139] 
[58]. Gabryelski W, Froese KL. Rapid and sensitive differentiation of anomers, linkage, and position 
isomers of disaccharides using High-Field Asymmetric Waveform Ion Mobility Spectrometry 
(FAIMS). J. Am. Soc. Mass Spectrom. 2003; 14:265–277. [PubMed: 12648934] 
[59]. Clowers BH, Dwivedi P, Steiner WE, Hill HHJ, Bendiak B. Separation of sodiated isobaric 
disaccharides and trisaccharides using electrospray ionization-atmospheric pressure ion mobility-
time of flight mass spectrometry. J. Am. Soc. Mass Spectrom. 2005; 16:660–669. [PubMed: 
15862767] 
[60]. Dwivedi P, Bendiak B, Clowers BH, Hill HHJ. Rapid resolution of carbohydrate isomers by 
electrospray ionization ambient pressure ion mobility spectrometry-time-of-flight mass 
spectrometry (ESI-APIMS-TOFMS). J. Am. Soc. Mass Spectrom. 2007; 18:1163–1175. 
[PubMed: 17532226] 
[61]. Yamagaki T, Sato A. Peak width-mass correlation in CID MS/MS of isomeric oligosaccharides 
using traveling-wave ion mobility mass spectrometry. J. Mass Spectrom. 2009; 44:1509–1517. 
[PubMed: 19753613] 
[62]. Yamagaki T, Sato A. Isomeric oligosaccharides analyses using negative-ion electrospray 
ionization ion mobility spectrometry combined with collision-induced dissociation MS/MS. 
Anal. Sci. 2009; 25:985–988. [PubMed: 19667474] 
[63]. Zhu M, Bendiak B, Clowers B, Hill HH. Ion mobility-mass spectrometry analysis of isomeric 
carbohydrate precursor ions. Anal. Bioanal. Chem. 2009; 394:1853–1867. [PubMed: 19562326] 
[64]. Schenauer MR, Meissen JK, Seo Y, Ames JB, Leary JA. Heparan sulfate separation, sequencing, 
and isomeric differentiation: Ion mobility spectrometry reveals specific iduronic and glucuronic 
acid-containing hexasaccharides. Anal. Chem. 2009; 81:10179–10185. [PubMed: 19925012] 
[65]. Fasciotti M, Sanvido GB, Santos VG, Lalli PM, McCullagh M, de Sá GF, Daroda RJ, Petera MG, 
Eberlina MN. Separation of isomeric disaccharides by traveling wave ion mobility mass 
spectrometry using CO2 as drift gas. J. Mass Spectrom. 2012; 27:1643–1647. [PubMed: 
23280753] 
[66]. Seo Y, Andaya A, Leary JA. Preparation, separation, and conformational analysis of differentially 
sulfated heparin octasaccharide isomers using ion mobility mass spectrometry. Anal. Chem. 
2012; 84:2416–2423. [PubMed: 22283665] 
Harvey et al. Page 17
J Mass Spectrom. Author manuscript; available in PMC 2017 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
[67]. Lee S, Valentine SJ, Reilly JP, Clemmer DE. Analyzing a mixture of disaccharides by IMS-
VUVPD-MS. Int. J. Mass Spectrom. 2012; 309:161–167. [PubMed: 22518093] 
[68]. Li H, Giles K, Bendiak B, Kaplan K, Siems WF, Hill HH Jr. Resolving structural isomers of 
monosaccharide methyl glycosides using drift tube and traveling wave ion mobility mass 
spectrometry. Anal. Chem. 2012; 84:3231–3239. [PubMed: 22339760] 
[69]. Li H, Bendiak B, Siems WF, Gang DR, Hill J, Herbert H. Ion mobility mass spectrometry 
analysis of isomeric disaccharide precursor, product and cluster ions. Rapid Commun. Mass 
Spectrom. 2013; 27:2699–2709. [PubMed: 24591031] 
[70]. Huang J-H, Bakx EJ, Gruppen H, Schols HA. Characterisation of 3-aminoquinoline-derivatised 
isomeric oligogalacturonic acid by travelling-wave ion mobility mass spectrometry. Rapid 
Commun. Mass Spectrom. 2013; 27:2279–2285. [PubMed: 24019194] 
[71]. Li H, Bendiak B, Kaplan K, Davis E, Siems WF. Evaluation of ion mobility-mass spectrometry 
for determining the isomeric heterogeneity of oligosaccharide-alditols derived from bovine 
submaxillary mucin. Int. J. Mass Spectrom. 2013; 352:9–18. H. HJH. [PubMed: 24634605] 
[72]. Huang Y, Dodds ED. Ion mobility studies of carbohydrates as group I adducts: Isomer specific 
collisional cross section dependence on metal ion radius. Anal. Chem. 2013; 85:9728–9735. 
[PubMed: 24033309] 
[73]. Li H, Bendiak B, Siems WF, Gang DR, Hill J, Herbert H. Carbohydrate structure characterization 
by tandem ion mobility mass spectrometry (IMMS)2. Anal. Chem. 2013; 85:2760–2769. 
[PubMed: 23330948] 
[74]. Fenn LS, McLean JA. Structural separations by ion mobility-MS for glycomics and 
glycoproteomics. Methods Molec. Biol. 2013; 951:171–194. [PubMed: 23296531] 
[75]. Li H, Bendiak B, Siems WF, Gang DR, Hill J, Herbert H. Determining the isomeric heterogeneity 
of neutral oligosaccharide-alditols of bovine submaxillary mucin using negative ion traveling 
wave ion mobility mass spectrometry. Anal. Chem. 2015; 87:2228–2235. [PubMed: 25594283] 
[76]. Gaye MM, Kurulugama R, Clemmer DE. Investigating carbohydrate isomers by IMS-CID-IMS-
MS: Precursor and fragment ion cross-sections. Analyst. 2015; 140:6922–6932. [PubMed: 
26306702] 
[77]. Hofmann J, Hahm HS, Seeberger PH, Pagel K. Identification of carbohydrate anomers using ion 
mobility-mass spectrometry. Nature. 2015; 526:241–244. [PubMed: 26416727] 
[78]. Huang Y, Dodds ED. Ion-neutral collisional cross sections of carbohydrate isomers as divalent 
cation adducts and their electron transfer products. Analyst. 2015; 140:6912–6921. [PubMed: 
26225371] 
[79]. Pettit ME, Harper B, Brantley MR, Solouki T. Collision-energy resolved ion mobility 
characterization of isomeric mixtures. Analyst. 2015; 140:6886–6896. [PubMed: 26222599] 
[80]. Kanu AB, Dwivedi P, Tam M, Matz L, Hill HHJ. Ion mobility-mass spectrometry. J. Mass 
Spectrom. 2008; 43:1–22. [PubMed: 18200615] 
[81]. Jackson SN, Colsch B, Egan T, Lewis EK, Schultz JA, Woods AS. Gangliosides' analysis by 
MALDI-ion mobility MS. Analyst. 2011; 136:463–466. [PubMed: 21113547] 
[82]. Struwe WB, Benesch JL, Harvey DJ, Pagel K. Collision cross sections of high-mannose N-
glycans in commonly observed adduct states - Identification of gas-phase conformers unique to 
[M-H]− ions. Analyst. 2015; 140:6799–6803. [PubMed: 26159123] 
[83]. Patel T, Bruce J, Merry A, Bigge C, Wormald M, Jaques A, Parekh R. Use of hydrazine to release 
in intact and unreduced form both N- and O-linked oligosaccharides from glycoproteins. 
Biochemistry. 1993; 32:679–693. [PubMed: 8422375] 
[84]. Wing DR, Field MC, Schmitz B, Thor G, Dwek RA, Schachner MS, Rademacher TW. The use of 
large-scale hydrazinolysis in the preparation of N-linked oligosaccharide libraries: application to 
brain tissue. Glycoconj. J. 1992; 9:293–301. [PubMed: 1305421] 
[85]. Fu D, Chen L, O'Neill RA. A detailed structural characterization of ribonuclease B 
oligosaccharides by 1H NMR spectroscopy and mass spectrometry. Carbohydr. Res. 1994; 
261:173–186. [PubMed: 7954510] 
[86]. Prien JM, Ashline DJ, Lapadula AJ, Zhang H, Reinhold VN. The high mannose glycans from 
bovine ribonuclease B isomer characterization by ion trap MS. J. Am. Soc. Mass Spectrom. 
2009; 20:539–556. [PubMed: 19181540] 
Harvey et al. Page 18
J Mass Spectrom. Author manuscript; available in PMC 2017 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
[87]. de Waard P, Koorevaar A, Kamerling JP, Vliegenthart JFG. Structure determination by 1H NMR 
spectroscopy of (sulfated) sialylated N-linked carbohydrate chains released from porcine 
thyroglobulin by peptide-N4-(N-acetyl-β-glucosaminyl)asparagine amidase-F. J. Biol. Chem. 
1991; 266:4237–4243. [PubMed: 1999416] 
[88]. Kamerling JP, Rijkse I, Maas AAM, van Kuik JA, Vliegenthart JFG. Sulfated N-linked 
carbohydrate chains in porcine thyroglobulin. FEBS Letts. 1988; 241:246–250. [PubMed: 
3197834] 
[89]. Da Silva MLC, Stubbs HJ, Tamura T, Rice KG. 1H-NMR characterization of a hen ovalbumin 
tyrosinamide N-linked oligosaccharide library. Arch. Biochem. Biophys. 1995; 318:465–475. 
[PubMed: 7733678] 
[90]. Harvey DJ, Wing DR, Küster B, Wilson IBH. Composition of N-linked carbohydrates from 
ovalbumin and co-purified glycoproteins. J. Am. Soc. Mass Spectrom. 2000; 11:564–571. 
[PubMed: 10833030] 
[91]. Yang Y, Barendregt A, Kamerling JP, Heck AJR. Analyzing protein micro-heterogeneity in 
chicken ovalbumin by high-resolution native mass spectrometry exposes qualitatively and semi-
quantitatively 59 proteoforms. Anal. Chem. 2013; 85:12037–12045. [PubMed: 24229052] 
[92]. Green ED, Adelt G, Baenziger JU, Wilson S, van Halbeek H. The asparagine-linked 
oligosaccharides on bovine fetuin. Structural analysis of N-glycanase-released oligosaccharides 
by 500-Megahertz 1H-NMR spectroscopy. J. Biol. Chem. 1988; 263:18253–18268. [PubMed: 
2461366] 
[93]. Küster B, Wheeler SF, Hunter AP, Dwek RA, Harvey DJ. Sequencing of N-linked 
oligosaccharides directly from protein gels: In-gel deglycosylation followed by matrix-assisted 
laser desorption/ionization mass spectrometry and normal-phase high performance liquid 
chromatography. Anal. Biochem. 1997; 250:82–101. [PubMed: 9234902] 
[94]. Börnsen KO, Mohr MD, Widmer HM. Ion exchange and purification of carbohydrates on a 
Nafion(R) membrane as a new sample pretreatment for matrix-assisted laser desorption-
ionization mass spectrometry. Rapid Commun. Mass Spectrom. 1995; 9:1031–1034.
[95]. Giles K, Pringle SD, Worthington KR, Little D, Wildgoose JL, Bateman RH. Applications of a 
travelling wave-based radio-frequency-only stacked ring ion guide. Rapid Commun. Mass 
Spectrom. 2004; 18:2401–2414. [PubMed: 15386629] 
[96]. Domon B, Costello CE. A systematic nomenclature for carbohydrate fragmentations in FAB-
MS/MS spectra of glycoconjugates. Glycoconj. J. 1988; 5:397–409.
[97]. Pringle SD, Giles K, Wildgoose JL, Williams JP, Slade SE, Thalassinos K, Bateman RH, Bowers 
MT, Scrivens JH. An investigation of the mobility separation of some peptide and protein ions 
using a new hybrid quadrupole/travelling wave IMS/oa-ToF instrument. Int. J. Mass Spectrom. 
2007; 261:1–12.
[98]. Bush MF, Hall Z, Giles K, Hoyes J, Robinson CV, Ruotolo BT. Collision cross sections of 
proteins and their complexes: A calibration framework and database for gas-phase structural 
biology. Anal. Chem. 2010; 82:9557–9565. [PubMed: 20979392] 
[99]. Pagel K, Natan E, Hall Z, Fersht AR, Robinson CV. Intrinsically disordered p53 and its 
complexes populate compact conformations in the gas phase. Angew. Chem. Int. Ed. 2013; 
52:361–365.
[100]. Pagel K, Harvey DJ. Ion mobility mass spectrometry of complex carbohydrates - collision cross 
sections of sodiated N-linked glycans. Anal. Chem. 2013; 85:5138–5145. [PubMed: 23621517] 
[101]. Thalassinos K, Grabenauer M, Slade SE, Hilton GR, Bowers MT, Scrivens JH. Characterization 
of phosphorylated peptides using traveling wave-based and drift cell ion mobility mass 
spectrometry. Anal. Chem. 2009; 81:248–254. [PubMed: 19117454] 
[102]. Hofmann J, Struwe WB, Scarff CA, Scrivens JH, Harvey DJ, Pagel K. Estimating collision 
cross sections of negatively charged N-glycans using travelling wave ion mobility-mass 
spectrometry. Anal. Chem. 2014; 86:10789–10795. [PubMed: 25268221] 
[103]. Forsythe JG, Petrov AS, Walker CA, Allen SJ, Pellissier JS, Bush MF, Huda NV, Fernández 
FM. Collision cross section calibrants for negative ion mode traveling wave ion mobility-mass 
spectrometry. Analyst. 2015 In press. 
Harvey et al. Page 19
J Mass Spectrom. Author manuscript; available in PMC 2017 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
[104]. Gelb AS, Jarratt RE, Huang Y, Dodds ED. A study of calibrant selection in measurement of 
carbohydrate and peptide ion-neutral collision cross sections by traveling wave ion mobility 
spectrometry. Anal. Chem. 2014; 86:11396–11402. [PubMed: 25329513] 
[105]. Struwe WB, Pagel K, Benesch JLP, Harvey DJ, Campbell MP. GlycoMob: An ion mobility-
mass spectrometry collision cross section database for glycomics. Glycoconj. J. 2015 In Press. 
[106]. Harvey DJ, Scrivens JH, Holland R, Williams JP, Wormald MR. Ion-mobility separation 
coupled with negative ion fragmentation of N-linked carbohydrates. Paper presented at the 56th 
ASMS Conference on Mass Spectrometry, Denver. 2008 Proceedings CD, MOG 09.10. 
[107]. Hermannová M, Iordache A-M, Slováková K, Havlíček V, Pelantová H, Lemr K. Arrival time 
distributions of product ions reveal isomeric ratio of deprotonated molecules in ion mobility– 
mass spectrometry of hyaluronan-derived oligosaccharides. J. Mass Spectrom. 2015; 50:854–
863. [PubMed: 26169140] 
[108]. Nishikaze T, Kaneshiro K, Kawabata S-i, Tanaka K. Structural analysis of N-glycans by the 
glycan-labeling method using 3-aminoquinoline-based liquid matrix in negative-ion MALDIMS. 
Anal. Chem. 2012; 84:9453–9461. [PubMed: 23072501] 
[109]. Harvey DJ, Edgeworth M, Krishna BA, Bonomelli C, Allman S, Crispin M, Scrivens JH. 
Fragmentation of negative ions from N-linked carbohydrates: Part 6: Glycans containing one N-
acetylglucosamine in the core. Rapid Commun. Mass Spectrom. 2014; 28:2008–2018. [PubMed: 
25132301] 
[110]. Hernandez O, Isenberg S, Steinmetz V, Glish GL, Maitre P. Probing mobility-selected 
saccharide isomers: Selective ion-molecule reactions and wavelength-specific IR activation. J. 
Phys. Chem. A. 2015; 119:6057–6064. [PubMed: 25827317] 
[111]. Mo F, Jensen LH. The crystal structure of a β-(1-4) linked disaccharide, α-N,N'- 
diacetylchitobiose monohydrate. Acta Crystallographica B. 1978; 34:1562–1569.
[112]. Mo F. On the conformational variability of the N-acetylglucosamin β-(1-4) linked dimer. Crystal 
and molecular structure of β-N,N'-diacetylchitobiose trihydrate. Acta Chem. Scand. A. 1979; 
33:207–218.
[113]. Woods RJ, Pathiaseril A, Wormald MR, Edge CJ, Dwek RA. The high degree of internal 
flexibility observed for an oligomannose oligosaccharide does not alter the overall topology of 
the molecule. Eur. J. Biochem. 1998; 258:372–386. [PubMed: 9874202] 
[114]. Orlean P. Architecture and biosynthesis of the. Saccharomyces cerevisiae cell wall. Genetics. 
2012; 192:775–818. [PubMed: 23135325] 
[115]. Dwek RA, Butters TD, Platt FM, Zitzmann N. Targeting glycosylation as a therapeutic 
approach. Nat. Rev. Drug Discov. 2002; 1:65–75. [PubMed: 12119611] 
[116]. Harvey DJ, Merry AH, Royle L, Campbell MP, Dwek RA, Rudd PM. Proposal for a standard 
system for drawing structural diagrams of N- and O-linked carbohydrates and related 
compounds. Proteomics. 2009; 9:3796–3801. [PubMed: 19670245] 
[117]. Chantret I, Kodali VP, Lahmouich C, Harvey DJ, Moore SEH. Endoplasmic reticulum-
associated degradation (ERAD) and free oligosaccharide generation in. Saccharomyces 
cerevisiae. J. Biol. Chem. 2011; 286:41786–41800. [PubMed: 21979948] 
Harvey et al. Page 20
J Mass Spectrom. Author manuscript; available in PMC 2017 March 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. 
Plot of cross sections against number of hexose residues for the [M+Na]+ ions from the 
high-mannose glycans. Numbers in bold are structure numbers from Scheme 1.
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Figure 2. 
Negative ion CID spectra ([M+H2PO4]− ions) of: (a) Man5GlcNAc2 (17, from gp120), (b) 
Man4GlcNAc2 (15, mobility-extracted, from gp120 as shown in Figure 4b), (c) Mixture of 
Man4GlcNAc2 (15 and 21 from gp120), (d) Man4GlcNAc2 (21, mobility-extracted, from 
gp120 as shown in Figure 4b), (e) Man3GlcNAc2 (19, from chicken ovalbumin). Symbols 
used for the structural diagrams in these and other spectra are as described in the legends to 
Schemes 1 and 2. Fragment ions are labelled according to the scheme proposed by Domon 
and Costello96.
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Figure 3. 
(a and b) relationship between collision cell voltage and fragment ion abundance for 
structurally-diagnostic fragment ions (a) and hexose + O-CH=CH-O− ion (b). (c) Negative 
ion CID spectrum ([M+H2PO4]− ion) of Man5GlcNAc2 recorded at 75 V on the collision 
cell, (d) Negative ion CID spectrum ([M+H2PO4]− ion) of Man5GlcNAc2 recorded at 105 V 
on the collision cell.
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Figure 4. 
(a) Negative ion ATD profile (unsmoothed) of Man4GlcNAc2 (15, 18, 21, [M+H PO ]− ions) 
from gp120. (b) ATDs of the diagnostic 6-antenna-specific fragment ions from 
Man4GlcNAc2 from gp120 (“Mean” smoothing algorithm from MassLynx, window size = 2, 
number of smooths = 2). Ions are identified as in Figure 2.
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Figure 5. 
(a) Negative ion ATD profile (unsmoothed) of Man6GlcNAc2 ([M+H2PO4]− ion) from 
gp120. (b) Single ion plots of the diagnostic 6-antenna-specific fragment ions from 
Man6GlcNAc2 obtained from gp120 (smoothing algorithm, mean 2×2). (c) Negative ion 
CID spectrum ([M+H2PO4]− ion) of Man6GlcNAc2 (d1 isomer, 14, from bovine 
thyroglobulin). (d) Negative ion CID spectrum ([M+H2PO4]− ion) of Man6GlcNAc2 (d2 
isomer, 12, from gp120 (JRCSF)). (e) Negative ion CID spectrum ([M+H2PO4]− ion) of 
Man6GlcNAc2 (d3 isomer, 13), extracted from the right-hand portion of the ATD peak 
shown in 5a and 5b.
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Figure 6. 
(a) Negative ion CID spectrum ([M+H2PO4]− ion) of Man7GlcNAc2 (d1d1 isomer, 11, from 
porcine thyroglobulin). (b) Negative ion CID spectrum ([M+H2PO4]− 8, from gp120, 
(JRCSF)). Negative ion CID spectrum ([M+H PO ]− ion) of Man7GlcNAc2 (d1d2 isomer, 
ion) of Man7GlcNAc2 (d1d3 isomer, 10, from gp120). The inset to the first panel shows 
single ion plots of the 6-antenna-specific ions (smoothing algorithm, mean 2×2) showing the 
presence of the minor isomer 11. The spectrum in panel c was, thus, from the right-hand 
portion of the ATD peak.
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Figure 7. 
(a) Negative ion ATD profile (smoothing algorithm, mean 2×2) of Man GlcNAc ([M+H 
PO ]− ion) from gp120. (b) Single ion plots of the diagnostic 6-antenna-specific fragment 
ions from Man8GlcNAc2 (mainly isomer 7) obtained from gp120 (smoothing algorithm, 
mean 2×2). (c) Negative ion ATD profiles (smoothing algorithm, mean 2×2) of the d1d1d2 
(5) and d1d1d3 (7) isomers of Man8GlcNAc2 ([M+H2PO4]− ions). Spectra were from 
different samples and normalized to 100%. (d) Negative ion CID spectrum ([M+H2PO4]− 
ion) of Man8GlcNAc2 (d1d1d3 isomer, 7, from gp120). (e) Negative ion CID spectrum ([M
+H2PO4] ion) of Man8GlcNAc2 (d1d1d2 isomer, 5, from a Saccharomyces cerevisiae 
mutanty117. (f) Negative ion CID spectrum ([M+H2PO4]− ion) of Man8GlcNAc2 (d1d2d3 
isomer, 6, from gp120 expressed in CHO cells in the presence of the α-mannosidase 
inhibitor NB-DNJ.
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Figure 8. 
Negative ion CID spectra ([M+H2PO4]− ion) of: (a) Man8GlcNAc2 (d1d1d3 isomer, 7, from 
gp120). (b) Man9GlcNAc2 (26, d1d1d3 isomer with an extra mannose residue at position 6 
of the internal mannose of the 3-antenna) from a Saccharomyces cerevisiae mutant (c) 
Man9GlcNAc2 (d1d1d2d3 isomer (4) and (d) Man10GlcNAc2 (27, d1d1d2d3 isomer with an 
extra mannose residue at position 6 of the internal mannose of the 3-antenna) from a 
Saccharomyces cerevisiae mutant.
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Figure 9. 
(a) Negative ion ATD profile (smoothing algorithm, mean 2×2) of Man9GlcNAc2 (4, [M
+H2PO4]− ion) from gp120. (b) Single ion plots of the diagnostic 6-antenna-specific 
fragment ions from Man9GlcNAc2 (4) obtained from gp120 (smoothing algorithm, mean 
2×2). (c) Negative ion ATD profile (smoothing algorithm, mean 2×2) of Man9GlcNAc2 (26, 
[M+H2PO4]− ion) from a Saccharomyces cerevisiae mutant. (b) Single ion plots of the 
diagnostic 6-antenna-specific fragment ions from Man9GlcNAc2 (26 obtained from a 
Saccharomyces cerevisiae mutant (smoothing algorithm, mean 2×2).
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Figure 10. 
Negative ion CID spectra ([M+H PO ]− ion) of: (a) Glc1Man7GlcNAc2 (25). (b) 
Glc3Man7GlcNAc2 (22). (c) Glc3Man8GlcNAc2 (23) and (d) Glc3Man9GlcNAc2 (1). 
Spectra b, c and d were from gp120 expressed in CHO cells in the presence of the α-
mannosidase inhibitor NB-DNJ. Inset 1 to panel a shows the ATD profiles for 
Glc3Man7-9GlcNAc2, Inset 2 shows the fragmentation of Glc3Man9GlcNAc2 (1).
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Figure 11. 
Plot of cross sections against number of hexose residues for the [M+H2PO4]− ions from the 
high-mannose glycans.
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Scheme 1. 
Biosynthesis of the high-mannose glycans. The arrows show the relationship between the 
various glycans but do not necessarily imply the existence of specific enzymatic pathways. 
Symbols used for the glycans are  = mannose,  = GlcNAc and  = glucose. Solid lines 
connecting the symbols are β-linkages, broken line are α-linkages. The angle of the lines 
shows the linkage position. For more information seey116.
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Scheme 2. 
Structure of the two glycans (26, 27) from yeast. Structures are drawn with the conventions 
outlined in Scheme 1.
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Table 1
, Positive ion cross section measurements for high-mannose N-glycans
Hexose Structure m/z[M+Na]+
Cross section data (Å2)
TW IM-MS Published lineara
Nitrogen Helium Nitrogen Helium
Cross
section SD n
Calculated
cross
section
Cross
section
(Å2)
Cross
section
(Å2)
3 19 933.3 303.5 1.19 3 219.3 294.2 209.7
5 17 1257.4 353.9 2.30 11 265.8 354.2 261.8
6 14 1419.5 376.3 2.05 11 286.2 376.1 278.2
7 Mainly 11 1581.5 396.4 1.89 10 304.6 396.8 300.4
8 7 1743.6 426.4 2.41 9 332.6 426.6 327.2
9 4 1905.6 449.2 2.33 9 353.7 456.2 346.9
a) Mean value from the glycans in ovalbumin, ribonuclease B and desialylated thyroglobulin.
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Table 3
, Fragment ions in the negative ion CID spectra that uniquely define the isomers of the high-mannose N-
glycans reported in this paper
Glycan Isomer No. m/z([M+H2PO4]−)
Structural evidence
D D-18 0,4
 A 0,3 A D’ D’-18
Man4 - 18 1169.3 485.2 467.2 413.1 395.1 - -
Man5 - 17 1331.4 647.2 629.2 575.2 545.2 323.1 305.1
Man6
d1 14
1493.5
647.2 629.2 575.2 545.2 323.1 305.1
d2 12 809.3 791.3 737.2 707.2 323.1 305.1
d3 13 809.3 791.3 737.2 707.2 485.2 467.2
Man7
d1d1 11
1655.5
647.2 629.2 575.2 545.2 323.1 305.1
d1d2 8 809.3 791.3 737.2 707.2 323.1 305.1
d1d3 10 809.3 791.3 737.2 707.2 485.2 467.2
d2d3 9 971.3 953.3 899.3 869.3 485.2 467.2
Man8 d1d1d2 5
1817.6
809.3 791.3 737.2 707.2 - -
d1d1d3 7 809.3 791.3 737.2 707.2 485.2 467.2
d1d2d3 6 971.3 953.3 899.2 869.3 485.2 467.2
Man9
d1d1d2d3 4 1979.6 971.3 953.3 899.3 869.3 485.2 467.2
26 1979.6 809.3 791.3 737.2 707.2 485.2 467.2
Man10 - 27 2141.7 971.3 9533 899.3 869.3 485.2 467.2
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